Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan J Conrad

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
ACS Chemical Biology|February 5, 2016
Therapeutics Targeting Protein Acetylation Perturb Latency of Human VirusesRyan J Conrad, Melanie Ott
Viruses|June 25, 2013
Bromodomain proteins in HIV infectionDaniela Boehm, Ryan J Conrad, Melanie Ott
Cell Host & Microbe|December 16, 2016
Retrovirus Integration: Some Assembly Required?Ibraheem Ali, Ryan J Conrad, Melanie Ott
Chemical Reviews|February 7, 2018
Lysine Acetylation Goes Global: From Epigenetics to Metabolism and TherapeuticsIbraheem Ali, Ryan J Conrad, Eric Verdin, et al.
Molecular Cell|August 29, 2017
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin-Remodeling ComplexesRyan J Conrad, Parinaz Fozouni, Sean Thomas, et al.
Molecular Cell|May 6, 2019
Crosstalk between RNA Pol II C-Terminal Domain Acetylation and Phosphorylation via RPRD ProteinsIbraheem Ali, Diego Garrido Ruiz, Zuyao Ni, et al.
EMBO Reports|May 14, 2025
NRF2 supports non-small cell lung cancer growth independently of CBP/p300-enhanced glutathione synthesisRyan J Conrad, James A Mondo, Mike Lingjue Wang, et al.
Cell Host & Microbe|December 16, 2016
The mTOR Complex Controls HIV LatencyEmilie Besnard, Shweta Hakre, Martin Kampmann, et al.
Nature Chemical Biology|December 28, 2022
Targeted degradation via direct 26S proteasome recruitmentCharlene Bashore, Sumit Prakash, Matthew C Johnson, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
ACS Chemical Biology|February 5, 2016
Therapeutics Targeting Protein Acetylation Perturb Latency of Human VirusesRyan J Conrad, Melanie Ott
Viruses|June 25, 2013
Bromodomain proteins in HIV infectionDaniela Boehm, Ryan J Conrad, Melanie Ott
Cell Host & Microbe|December 16, 2016
Retrovirus Integration: Some Assembly Required?Ibraheem Ali, Ryan J Conrad, Melanie Ott
Chemical Reviews|February 7, 2018
Lysine Acetylation Goes Global: From Epigenetics to Metabolism and TherapeuticsIbraheem Ali, Ryan J Conrad, Eric Verdin, et al.
Molecular Cell|August 29, 2017
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin-Remodeling ComplexesRyan J Conrad, Parinaz Fozouni, Sean Thomas, et al.
Molecular Cell|May 6, 2019
Crosstalk between RNA Pol II C-Terminal Domain Acetylation and Phosphorylation via RPRD ProteinsIbraheem Ali, Diego Garrido Ruiz, Zuyao Ni, et al.
EMBO Reports|May 14, 2025
NRF2 supports non-small cell lung cancer growth independently of CBP/p300-enhanced glutathione synthesisRyan J Conrad, James A Mondo, Mike Lingjue Wang, et al.
Cell Host & Microbe|December 16, 2016
The mTOR Complex Controls HIV LatencyEmilie Besnard, Shweta Hakre, Martin Kampmann, et al.
Nature Chemical Biology|December 28, 2022
Targeted degradation via direct 26S proteasome recruitmentCharlene Bashore, Sumit Prakash, Matthew C Johnson, et al.
Pageof 1